G Bouras1, S R Markar1, E M Burns1, J R Huddy1, A Bottle2, T Athanasiou1, A Darzi1, G B Hanna3. 1. Department of Surgery & Cancer, Imperial College London, United Kingdom. 2. Dr Foster Unit, Department of Primary Care and Public Health, Imperial College, London, United Kingdom. 3. Department of Surgery & Cancer, Imperial College London, United Kingdom. Electronic address: h.hanna@imperial.ac.uk.
Abstract
BACKGROUND: The objective was to evaluate incidence, risk factors and impact of postoperative symptoms following esophagogastric cancer resection in primary care. METHODS: Patients undergoing esophagogastrectomy for cancer from 1998 to 2010 with linked records in Clinical Practice Research Datalink, Hospital Episodes Statistics and Office of National Statistics databases were studied. The recording of codes for reflux, dysphagia, dyspepsia, nausea, vomiting, dumping, diarrhea, steatorrhea, appetite loss, weight loss, pain and fatigue were identified up to 12 months postoperatively. Psychiatric morbidity was also examined and its risk evaluated by logistic regression analysis. RESULTS: Overall, 58.6% (1029/1755) of patients were alive 2 years after surgery. Of these, 41.1% had recorded postoperative symptoms. Reflux, dysphagia, dyspepsia and pain were more frequent following esophagectomy compared with gastrectomy (p < 0.05). Complications (OR = 1.40 95%CI 1.00-1.95) and surgical procedure predicted postoperative symptoms (p < 0.05). When compared with partial gastrectomy, esophagectomy (OR = 2.03 95%CI 1.26-3.27), total gastrectomy (OR = 2.44 95%CI 1.57-3.79) and esophagogastrectomy (OR = 2.66 95%CI 1.85-2.86) were associated with postoperative symptoms (p < 0.05). The majority of patients with postoperative psychiatric morbidity had depression or anxiety (98%). Predictors of postoperative depression/anxiety included younger age (OR = 0.97 95%CI 0.96-0.99), complications (OR = 2.40 95%CI 1.51-3.83), psychiatric history (OR = 6.73 95%CI 4.25-10.64) and postoperative symptoms (OR = 1.78 95%CI 1.17-2.71). CONCLUSIONS: Over 40% of patients had symptoms related to esophagogastric cancer resection recorded in primary care, and were associated with an increase in postoperative depression and anxiety.
BACKGROUND: The objective was to evaluate incidence, risk factors and impact of postoperative symptoms following esophagogastric cancer resection in primary care. METHODS:Patients undergoing esophagogastrectomy for cancer from 1998 to 2010 with linked records in Clinical Practice Research Datalink, Hospital Episodes Statistics and Office of National Statistics databases were studied. The recording of codes for reflux, dysphagia, dyspepsia, nausea, vomiting, dumping, diarrhea, steatorrhea, appetite loss, weight loss, pain and fatigue were identified up to 12 months postoperatively. Psychiatric morbidity was also examined and its risk evaluated by logistic regression analysis. RESULTS: Overall, 58.6% (1029/1755) of patients were alive 2 years after surgery. Of these, 41.1% had recorded postoperative symptoms. Reflux, dysphagia, dyspepsia and pain were more frequent following esophagectomy compared with gastrectomy (p < 0.05). Complications (OR = 1.40 95%CI 1.00-1.95) and surgical procedure predicted postoperative symptoms (p < 0.05). When compared with partial gastrectomy, esophagectomy (OR = 2.03 95%CI 1.26-3.27), total gastrectomy (OR = 2.44 95%CI 1.57-3.79) and esophagogastrectomy (OR = 2.66 95%CI 1.85-2.86) were associated with postoperative symptoms (p < 0.05). The majority of patients with postoperative psychiatric morbidity had depression or anxiety (98%). Predictors of postoperative depression/anxiety included younger age (OR = 0.97 95%CI 0.96-0.99), complications (OR = 2.40 95%CI 1.51-3.83), psychiatric history (OR = 6.73 95%CI 4.25-10.64) and postoperative symptoms (OR = 1.78 95%CI 1.17-2.71). CONCLUSIONS: Over 40% of patients had symptoms related to esophagogastric cancer resection recorded in primary care, and were associated with an increase in postoperative depression and anxiety.
Authors: Sheraz R Markar; Melody Ni; Suzanne S Gisbertz; Leonie van der Werf; Jennifer Straatman; Donald van der Peet; Miguel A Cuesta; George B Hanna; Mark I van Berge Henegouwen Journal: J Clin Oncol Date: 2020-05-18 Impact factor: 44.544
Authors: Rebecca A Aslakson; Shivani V Chandrashekaran; Elizabeth Rickerson; Bridget N Fahy; Fabian M Johnston; Judith A Miller; Alison Conca-Cheng; Suwei Wang; Arden M Morris; Karl Lorenz; Jennifer S Temel; Thomas J Smith Journal: J Palliat Med Date: 2019-09 Impact factor: 2.947
Authors: Nora K Horick; Ariela Muzikansky; Hilda L Gutierrez; Kristina L Boyd; Dianne M Finkelstein Journal: J Cancer Surviv Date: 2018-10-12 Impact factor: 4.442
Authors: Sheraz Rehan Markar; Ewen A Griffiths; Paul Behrens; Pritam Singh; Ravi S Vohra; James Gossage; Tim Underwood; George B Hanna Journal: BMJ Open Date: 2020-06-03 Impact factor: 2.692
Authors: Nadia N Khan; Ashika Maharaj; Sue Evans; Charles Pilgrim; John Zalcberg; Wendy Brown; Paul Cashin; Daniel Croagh; Natasha Michael; Jeremy Shapiro; Kate White; Liane Ioannou Journal: BMC Health Serv Res Date: 2022-02-17 Impact factor: 2.655